Division of Allergy Pulmonary and Critical Care Medicine Archives
Study finds administering IV fluids during emergency tracheal intubation does not lower cardiac arrest risk
Jun. 20, 2022—Rapidly administering IV fluids to critically ill adults undergoing emergency tracheal intubation does not significantly decrease chances of hypotension (low blood pressure) and cardiac arrest, a Vanderbilt University Medical Center-led study shows.
Jun. 2, 2022—Vanderbilt researchers found that prone positioning of patients with COVID-19-related hypoxemia not on mechanical ventilation offered no observed clinical benefit among these patients.
Mar. 10, 2022—A Vanderbilt study shows that physicians can safely identify and disprove low-risk penicillin allergies using an oral amoxicillin challenge in consenting patients, even those in the intensive care unit who are recovering from critical illness.
Sep. 1, 2021—Vanderbilt University Hospital treated 39 pregnant patients hospitalized with active COVID-19 infections in August, 10 of whom were admitted to the intensive care unit (ICU).
May. 20, 2021—Type 2 diabetes patients who also have asthma are benefitting from a diabetes medication, typically given to help the pancreas produce more insulin, that also improves asthma symptoms and may reduce lung and airway inflammation.
May. 17, 2021—Richard Light, MD, professor of Medicine in the Division of Allergy, Pulmonary and Critical Care, died May 11 from injuries he sustained from a fall. He was 79.
Mar. 25, 2021—An FDA-approved medication enhances the function of T regulatory cells (Treg), a class of immune cells that restrains the immune response, Vanderbilt investigators have discovered.
Feb. 4, 2021—Life with emphysema, a lung condition that causes shortness of breath, can be miserable. People with advanced emphysema, a form of chronic obstructive pulmonary disease (COPD), are so short of breath they may need supplemental oxygen just to walk from room to room. They often have trouble with everyday tasks like bathing or cooking a meal.
Jul. 23, 2020—Todd Rice, MD, MSc, has been appointed vice president for Clinical Trial Innovation and Operations in the Vanderbilt Institute for Clinical and Translational Research (VICTR).